News
Chipotle Mexican Grill (CMG) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Chipotle Mexican Grill (CMG) closed at $28.18, marking a -1.95% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.41%
Agnico Eagle Mines (AEM) Outpaces Stock Market Gains: What You Should Know
Agnico Eagle Mines (AEM) closed at $176.75 in the latest trading session, marking a +2.97% move from the prior day. This move outpaced the S&P 500's daily gain of 0.41%. At the same time, the Dow
Planet Labs PBC (PL) Reports Q1 Loss, Beats Revenue Estimates
Planet Labs PBC (PL) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to break-even earnings per share a year ago. These figures are
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
In the latest close session, Viking Therapeutics, Inc. (VKTX) was up +1.53% at $29.78. The stock outpaced the S&P 500's daily gain of 0.41%. On the other hand, the Dow registered a gain of 1.73%
Quanex Building Products (NX) Tops Q2 Earnings and Revenue Estimates
Quanex Building Products (NX) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.6 per share a year ago
The Cooper Companies (COO) Beats Q2 Earnings and Revenue Estimates
The Cooper Companies (COO) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $0.96 per share a year ago. These
Here's What Key Metrics Tell Us About Rubrik, Inc. (RBRK) Q1 Earnings
Rubrik, Inc. (RBRK) reported $387.07 million in revenue for the quarter ended April 2026, representing a year-over-year increase of 39%. EPS of $0.16 for the same period compares to -$0.15 a year
Lululemon (LULU) Q1 Earnings and Revenues Surpass Estimates
Lululemon (LULU) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $2.6 per share a year ago. These figures
Zumiez (ZUMZ) Reports Q1 Loss, Beats Revenue Estimates
Zumiez (ZUMZ) came out with a quarterly loss of $0.82 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to a loss of $0.79 per share a year ago. These figures are
ServiceTitan Inc. (TTAN) Q1 Earnings and Revenues Surpass Estimates
ServiceTitan Inc. (TTAN) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.18 per share a year ago. These
Rubrik, Inc. (RBRK) Q1 Earnings and Revenues Surpass Estimates
Rubrik, Inc. (RBRK) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.15 per share a year ago
DocuSign (DOCU) Q1 Earnings and Revenues Beat Estimates
DocuSign (DOCU) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $0.9 per share a year ago. These figures are
Samsara Inc. (IOT) Beats Q1 Earnings and Revenue Estimates
Samsara Inc. (IOT) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago. These
Guidewire Software (GWRE) Q3 Earnings and Revenues Top Estimates
Guidewire Software (GWRE) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.88 per share a year ago. These
Argan (AGX) Q1 Earnings and Revenues Surpass Estimates
Argan (AGX) came out with quarterly earnings of $3.24 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $1.6 per share a year ago. These figures are
Torrid Holdings (CURV) Reports Break-Even Earnings for Q1
Torrid Holdings (CURV) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.06 per share a year ago. These figures
Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart
Thursday, June 4, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire
What Do Retail Earnings Reports Tell Us About Consumer Spending Trends?
Retail sector CEOs have historically cited all kinds of factors in explaining operating underperformance, but their tentative tone on the Q1 earnings calls was largely justified given the uncertain
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
Key Points
- Interested in Aclaris Therapeutics, Inc.? Here are five stocks we like better.
- Aclaris Therapeutics is preparing a packed clinical calendar, with data expected in the second half of
Buy This Quantum Stock in June as IonQ and Rigetti Face Pressure
The quantum computing space is gaining massive momentum in the race to become Wall Street's hottest opportunity in 2026. This is all because federal funding is accelerating, enterprise interest is
The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro in Focus
Key Points
- Interested in Hewlett Packard Enterprise Company? Here are five stocks we like better.
- Established technology hardware makers are successfully capturing new opportunities as the demand
Will Berkshire's Taylor Morrison Deal Strengthen its Housing Bet?
Berkshire Hathaway's BRK.B planned $6.8 billion acquisition of Taylor Morrison Home Corp. represents a strategic deployment of capital into a well-established homebuilder with significant exposure
Here's Why You Should Retain DexCom Stock in Your Portfolio
DexCom, Inc. DXCM is well-positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong first-quarter 2026
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference
Key Points
- Interested in Adicet Bio, Inc.? Here are five stocks we like better.
- Adicet Bio is prioritizing its autoimmune lead program prula-cel (ADI-001), with the next update expected to


